Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
16.22
-0.67 (-3.97%)
At close: Sep 18, 2024, 4:00 PM
16.21
-0.01 (-0.06%)
After-hours: Sep 18, 2024, 4:01 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $1.02 billion as of September 18, 2024. Its market cap has increased by 81.26% in one year.
Market Cap
1.02B
Enterprise Value
1.06B
1-Year Change
81.26%
Ranking
Category
Stock Price
$16.22
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $1.02B, an increase of 277.22%. That is a compound annual growth rate of 22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 1.07B | 77.09% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.13B |
| Tango Therapeutics | 1.13B |
| Tyra Biosciences | 1.12B |
| Silk Road Medical | 1.12B |
| Vir Biotechnology | 1.11B |
| Calliditas Therapeutics AB | 1.09B |
| OPKO Health | 1.09B |
| Autolus Therapeutics | 1.09B |